Sources

12 Total Sources

Biogen to Buy RayThera for Up to $1 Billion, Expanding Immunology Pipeline

Center75%

Right25%

Biogen | Investor Relations1d ago

Biogen to Acquire RayThera Inc. for $1 Billion, Expanding Immunology Pipeline

Biogen targets immunology growth with $1 billion RayThera deal | Reuters

StockTitan1d ago

Biogen to buy RayThera for up to $1B | BIIB Stock News

intellectia.ai1d ago

Biogen to Acquire RayThera for Up to $1B | Intellectia.AI

Yahoo Finance1d ago

Biogen to acquire RayThera for $1 billion

Biogen's $1 Billion RayThera Bet: Smart Pipeline Replenishment or Another Immunology Gamble?

Asianet Newsable6h ago

BIIB Stock: Biogen Strengthens Immunology Pipeline In Up To $1B RayThera Deal | Asianet Newsable

BIIB - Biogen 🔹Expands Immunology Pipeline with Agreement to Acquire RayThera Inc. 🔹Potential deal value up to $1 billion, mostly milestone-based 🔹Acquisition adds multiple anti-inflammatory immunology assets to Biogen's pipeline 🔹Lead candidate

The Globe and Mail22h ago

Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc. - The Globe and Mail

Marketscreener.com1d ago

Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc. | MarketScreener

GuruFocus.com1d ago

Biogen to Acquire RayThera for Up to $1 Billion

Biogen to Acquire RayThera in an Up to $1B Deal to Expand Drug Pipeline - TipRanks.com